
Data on hormone therapy (HT) for treating menopause-related symptoms and preventing disease in postmenopausal women are evolving rapidly. To guide therapy and to put the risks and benefits of HT, estrogen therapy (ET), or combined estrogen-progestogen therapy (EPT) in perspective for healthcare professionals and the public, the North American Menopause Society (NAMS) has updated its evidence-based 2008 statement in light of subsequently published scientific data.